Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis

Laura Miquel, Lise Preaubert, Audrey Gnisci, Noémie Resseguier, Audrey Pivano, Jeanne Perrin, Blandine Courbiere, Laura Miquel, Lise Preaubert, Audrey Gnisci, Noémie Resseguier, Audrey Pivano, Jeanne Perrin, Blandine Courbiere

Abstract

Objective: To examine the impact of ethanol sclerotherapy (EST) for endometrioma on in vitro fertilization (IVF) cumulative live birth rates (CLBR) in women with moderate-severe endometriosis.

Methods: This retrospective cohort study included women with moderate-severe endometriosis (revised American Fertility Society stage III-IV) and endometrioma who underwent IVF with the ultra-long agonist protocol. We compared two groups: women undergoing EST for endometrioma before IVF (EST group), and women whose endometrioma was left in situ during IVF (No-EST group). The primary outcome was the CLBR per IVF cycle, including fresh and frozen embryo transfers. The secondary endpoints included the complication rate, number of mature oocytes retrieved, clinical pregnancy rate and pregnancy loss rate.

Results: Seventy-four women were included in the study, with 37 in the EST group and 37 in the No-EST group, representing 67 and 69 IVF cycles, respectively. The population and cycle characteristics were comparable between the two groups, especially the ovarian response to stimulation. The CLBR was significantly increased in the EST group compared to the No-EST group (31.3% vs. 14.5%, p = 0.03). The clinical and biochemical pregnancy rates were significantly increased in the EST group (37.3% vs. 15.9%, p = 0.01 and 43.3% vs. 23.2%, p = 0.01, respectively). Multivariate analysis revealed a significantly increased chance of live birth in women exposed to EST before IVF with an adjusted OR of 2.68 (95% confidence interval, CI: 1.13-6.36, p = 0.02). In the EST group, we reported one major complication Clavien and Dindo classification grade III, complication involving an ovarian abscess that required a laparoscopic drainage.

Conclusions: EST is an interesting technique to improve IVF success rates in women with moderate-severe endometriosis. EST could be discussed before IVF in infertile women.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009. July;92(1):68–74. 10.1016/j.fertnstert.2008.04.056
    1. Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019. September 11;25(5):592–632. 10.1093/humupd/dmz012
    1. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997. May;67(5):817–21. 10.1016/s0015-0282(97)81391-x
    1. Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson J-B. Management of ovarian endometriomas. Hum Reprod Update. 2002. December;8(6):591–7. 10.1093/humupd/8.6.591
    1. Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008. April 16;(2):CD004992 10.1002/14651858.CD004992.pub3
    1. Nezhat C, Crowgey S, Nezhat F. Videolaseroscopy for the treatment of endometriosis associated with infertility. Fertil Steril. 1989. February;51(2):237–40. 10.1016/s0015-0282(16)60483-1
    1. Vercellini P, Fedele L, Aimi G, De Giorgi O, Consonni D, Crosignani PG. Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod Oxf Engl. 2006. October;21(10):2679–85.
    1. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod Oxf Engl. 2009. March;24(3):496–501.
    1. Wallace WHB, Kelsey TW. Human ovarian reserve from conception to the menopause. PloS One. 2010. Jan 27;5(1):e8772 10.1371/journal.pone.0008772
    1. Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome. Hum Reprod. 2015. April 1;30(4):840–7. 10.1093/humrep/dev029
    1. Dunselman G a. J, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod Oxf Engl. 2014. March;29(3):400–12.
    1. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015. December;21(6):809–25. 10.1093/humupd/dmv035
    1. Benaglia L, Busnelli A, Biancardi R, Vegetti W, Reschini M, Vercellini P, et al. Oocyte retrieval difficulties in women with ovarian endometriomas. Reprod Biomed Online. 2018. Jul;37(1):77–84. 10.1016/j.rbmo.2018.03.020
    1. Gupta S, Agarwal A, Agarwal R, Loret de Mola JR. Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online. 2006. September;13(3):349–60. 10.1016/s1472-6483(10)61439-3
    1. Somigliana E, Benaglia L, Paffoni A, Busnelli A, Vigano P, Vercellini P. Risks of conservative management in women with ovarian endometriomas undergoing IVF. Hum Reprod Update. 2015. August;21(4):486–99. 10.1093/humupd/dmv012
    1. Aboulghar MA, Mansour RT, Serour GI, Sattar M, Ramzy AM, Amin YM. Treatment of recurrent chocolate cysts by transvaginal aspiration and tetracycline sclerotherapy. J Assist Reprod Genet. 1993. November;10(8):531–3. 10.1007/BF01204365
    1. Agostini A, De Lapparent T, Collette E, Capelle M, Cravello L, Blanc B. In situ methotrexate injection for treatment of recurrent endometriotic cysts. Eur J Obstet Gynecol Reprod Biol. 2007. Jan;130(1):129–31. 10.1016/j.ejogrb.2006.01.015
    1. Shawki HE, Elmorsi M, Samir A, Eissa MK. In situ methotrexate injection after transvaginal ultrasound-guided aspiration of ovarian endometriomas: A randomized controlled trial. Middle East Fertil Soc J. 2011. September 1;16(3):224–31.
    1. Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017. July;108(1):117–124.e5. 10.1016/j.fertnstert.2017.05.015
    1. Hsieh C-L, Shiau C-S, Lo L-M, Hsieh T-T, Chang M-Y. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril. 2009. June;91(6):2709–13. 10.1016/j.fertnstert.2008.03.056
    1. Wang S-M, Cai H-Q, Dong X-Q, Fan Q-L, Wang L-L, Shao X-H, et al. Correlation between ovarian chocolate cyst and serum carbohydrate antigen 125 level and the effect of ultrasound-guided interventional sclerotherapy on serum carbohydrate antigen 125 level. J Obstet Gynaecol Res. 2015. January;41(1):92–8. 10.1111/jog.12491
    1. Yazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, et al. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009. July;19(1):121–5. 10.1016/s1472-6483(10)60055-7
    1. Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. [Ultrasonically guided puncture of endometrial cysts—aspiration of contents and infusion of ethanol]. Nihon Sanka Fujinka Gakkai Zasshi. 1988. February;40(2):187–91.
    1. Gatta G, Parlato V, Di Grezia G, Porto A, Cappabianca S, Grassi R, et al. Ultrasound-guided aspiration and ethanol sclerotherapy for treating endometrial cysts. Radiol Med (Torino). 2010. December;115(8):1330–9.
    1. Aflatoonian A, Rahmani E, Rahsepar M. Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: A randomized clinical trial. Iran J Reprod Med. 2013. March;11(3):179–84.
    1. Kikuchi I, Takeuchi H, Kitade M, Shimanuki H, Kumakiri J, Kinoshita K. Recurrence rate of endometriomas following a laparoscopic cystectomy. Acta Obstet Gynecol Scand. 2006;85(9):1120–4. 10.1080/00016340600627154
    1. Rubod C, Jean Dit Gautier E, Yazbeck C. [Surgical management of endometrioma: Different alternatives in term of pain, fertility and recurrence. CNGOF-HAS Endometriosis Guidelines]. Gynecol Obstet Fertil Senol. 2018. March;46(3):278–89. 10.1016/j.gofs.2018.02.013
    1. Miquel L, Preaubert L, Gnisci A, Netter A, Courbiere B, Agostini, et al. Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps. Fertility and Sterility. in press.
    1. André GM, Vilarino FL, Christofolini DM, Bianco B, Barbosa CP. Aspiration and ethanol sclerotherapy to treat recurrent ovarian endometriomas prior to in vitro fertilization—a pilot study. Einstein Sao Paulo Braz. 2011. December;9(4):494–8.
    1. Lee K-H, Kim C-H, Lee Y-J, Kim S-H, Chae H-D, Kang B-M. Surgical resection or aspiration with ethanol sclerotherapy of endometrioma before in vitro fertilization in infertilie women with endometrioma. Obstet Gynecol Sci. 2014. July;57(4):297–303. 10.5468/ogs.2014.57.4.297
    1. Suganuma N, Wakahara Y, Ishida D, Asano M, Kitagawa T, Katsumata Y, et al. Pretreatment for ovarian endometrial cyst before in vitro fertilization. Gynecol Obstet Invest. 2002;54 Suppl 1:36–40; discussion 41–42.
    1. Yazbeck C, Koskas M, Cohen Scali S, Kahn V, Luton D, Madelenat P. [How I do… ethanol sclerotherapy for ovarian endometriomas]. Gynécologie Obstétrique Fertil. 2012. Oct;40(10):620–2.
    1. Bazot M, Bornier C, Dubernard G, Roseau G, Cortez A, Daraï E. Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis. Hum Reprod Oxf Engl. 2007. May;22(5):1457–63.
    1. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019. November;15(11):666–82. 10.1038/s41574-019-0245-z
    1. Guerriero S, Saba L, Pascual MA, Ajossa S, Rodriguez I, Mais V, et al. Transvaginal ultrasound vs magnetic resonance imaging for diagnosing deep infiltrating endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2018. May;51(5):586–95.
    1. Zanardi R, Del Frate C, Zuiani C, Bazzocchi M. Staging of pelvic endometriosis based on MRI findings versus laparoscopic classification according to the American Fertility Society. Abdom Imaging. 2003. October 1;28(5):733–42. 10.1007/s00261-003-0005-2
    1. Dindo D, Demartines N, Clavien P-A. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg. 2004. August;240(2):205–13. 10.1097/
    1. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017. September 1;108(3):393–406. 10.1016/j.fertnstert.2017.06.005
    1. Flynn TN. Design and Analysis of Cluster Randomization Trials in Health Research. Allan Donner and Neil Klar. London: Arnold, 2000, pp.178, £35.00. ISBN: 0-340-69153-0. Int J Epidemiol. 2001. April 1;30(2):407–8.
    1. González-Foruria I, Soldevila PB, Rodríguez I, Rodríguez-Purata J, Pardos C, García S, et al. Do ovarian endometriomas affect ovarian response to ovarian stimulation for IVF/ICSI? Reprod Biomed Online. 2020. July;41(1):37–43. 10.1016/j.rbmo.2020.03.013
    1. Terzic M, Aimagambetova G, Garzon S, Bapayeva G, Ukybassova T, Terzic S, et al. Ovulation induction in infertile women with endometriotic ovarian cysts: current evidence and potential pitfalls. Minerva Med. 2020. February;111(1):50–61. 10.23736/S0026-4806.19.06346-8
    1. Somigliana E, Viganò P, Benaglia L, Busnelli A, Paffoni A, Vercellini P. Ovarian stimulation and endometriosis progression or recurrence: a systematic review. Reprod Biomed Online. 2019. February;38(2):185–94. 10.1016/j.rbmo.2018.11.021
    1. Guo Y, Lu N, Zhang Y, Su Y, Wang Y, Zhang Y, et al. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone. Contemp Clin Trials. 2012. November;33(6):1206–10. 10.1016/j.cct.2012.07.009
    1. Gonçalves FC, Andres MP, Passman LJ, Gonçalves MOC, Podgaec S. A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2016. July;134(1):3–7.
    1. Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, et al. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int J Mol Sci. 2019. November 10;20(22).
    1. Riemma G, Laganà AS, Schiattarella A, Garzon S, Cobellis L, Autiero R, et al. Ion Channels in The Pathogenesis of Endometriosis: A Cutting-Edge Point of View. Int J Mol Sci. 2020. February 7;21(3).
    1. Molloy D, Martin M, Speirs A, Lopata A, Clarke G, McBain J, et al. Performance of patients with a “frozen pelvis” in an in vitro fertilization program. Fertil Steril. 1987. March;47(3):450–5. 10.1016/s0015-0282(16)59054-2
    1. Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Interv Radiol. 2010. December;27(4):391–9.
    1. Wang L-L, Cai H-Q, Dong X-Q, Zhang L-W, Jiang S-S, Zhao N, et al. Differentially expressed gene profiles in the serum before and after the ultrasound-guided ethanol sclerotherapy in patients with ovarian endometriomas. Clin Biochem. 2015. November 1;48(16):1131–7.
    1. Santulli P, Marcellin L, Menard S, Thubert T, Khoshnood B, Gayet V, et al. Increased rate of spontaneous miscarriages in endometriosis-affected women. Hum Reprod Oxf Engl. 2016. May;31(5):1014–23.
    1. Garcia-Tejedor A, Martinez-Garcia JM, Candas B, Suarez E, Mañalich L, Gomez M, et al. Ethanol Sclerotherapy versus Laparoscopic Surgery for Endometrioma Treatment: A Prospective, Multicenter, Cohort Pilot Study. J Minim Invasive Gynecol. 2020. July 1;27(5):1133–40. 10.1016/j.jmig.2019.08.036
    1. Findeklee S, Radosa JC, Hamza A, Haj Hamoud B, Iordache I, Sklavounos P, et al. Treatment algorithm for women with endometriosis in a certified Endometriosis Unit. Minerva Ginecol. 2020 Feb;72(1):43–9.
    1. Han K, Seo SK, Kim M-D, Kim GM, Kwon JH, Kim HJ, et al. Catheter-directed Sclerotherapy for Ovarian Endometrioma: Short-term Outcomes. Radiology. 2018;289(3):854–9. 10.1148/radiol.2018180606

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere